Trials / Completed
CompletedNCT04631874
A Clinical Trial to Compare Pharmacokinetics of the "CDFF0318" and "Champix Tab. 1mg"
A Phase 1 Clinical Trial to Compare and Evaluate Safety and Pharmacokinetic Characteristics After Administration of the "CDFF0318" and "Champix Tab. 1mg (Varenicline Tartrate)" in Healthy Male Volunteers
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 32 (actual)
- Sponsor
- CTC Bio, Inc. · Industry
- Sex
- Male
- Age
- 19 Years – 45 Years
- Healthy volunteers
- Accepted
Summary
A Phase 1 Clinical Trial to Compare and Evaluate Safety and Pharmacokinetic Characteristics after Administration of the "CDFF0318" and "Champix Tab. 1mg (Varenicline tartrate)" in Healthy Male Volunteers
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | CDFF0318, Champix | CDFF0318: Varenicline salt changed Champix: Varenicline tartrate |
Timeline
- Start date
- 2019-07-24
- Primary completion
- 2020-05-01
- Completion
- 2020-05-01
- First posted
- 2020-11-17
- Last updated
- 2020-11-17
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT04631874. Inclusion in this directory is not an endorsement.